Search Results 1531-1540 of 16885 for monoclonal antibody
Received treatment with a Food and Drug Administration approved PD-1 blocking antibody for 12 weeks or longer;; Have PD (according to RECIST v1.1) within 12 ...
... antibodies against microorganisms, and inflammatory markers (e.g., leukocyte esterase, CRP) in synovial fluid for the diagnosis of prosthetic joint ...
Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease. Jennifer O'Hara. August 2, 2020. Health & Wellness. Safety measures before ...
... antibody. Read More on PubMed. Additional contact information. Cancer-related trials contact form. Phone: 855-776-0015 (toll-free). International patient ...
The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the ...
... antibody and anthracycline containing first-line therapy for disease under study. Note: The time of relapse is calculated from the date of the first disease ...
Subjects with positive hepatitis B virus core antibody are excluded only if they have concurrent negative hepatitis B surface antibody or detectable serum ...
... antibody specific for their deceased donor. It is our hypothesis that blockade of terminal complement activation with eculizumab at the time of transplant ...
Previous treatment with pembrolizumab, nivolumab, or other programmed cell death-1 antibody (anti- PD-1) or PD-1 ligand-antibody (anti-PD-L1) agents. New ...
Learn about this procedure that replaces unhealthy bone marrow with stem cells. Your own cells, donor cells or cells from umbilical cord blood may be used.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.